Sourya Shrestha
Overview
Explore the profile of Sourya Shrestha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
836
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shrestha S, Cilloni L, Beeler Asay G, Kammerer J, Raz K, Shaw T, et al.
Emerg Infect Dis
. 2025 Mar;
31(3):497-506.
PMID: 40023804
Outbreak investigation is an essential component of tuberculosis (TB) control in the United States, but its epidemiologic impact and cost-effectiveness have not been quantified. We modeled outbreak investigation activities in...
2.
Shrestha S, Mishra G, Hamal M, Dhital R, Shrestha S, Shrestha A, et al.
BMJ Open
. 2023 Nov;
13(11):e062123.
PMID: 37914308
Objectives: Active case finding (ACF) is an important tuberculosis (TB) intervention in high-burden settings. However, empirical evidence garnered from field data has been equivocal about the long-term community-level impact, and...
3.
Brummer L, Thompson R, Malhotra A, Shrestha S, Kendall E, Andrews J, et al.
Clin Infect Dis
. 2023 Aug;
78(1):154-163.
PMID: 37623745
Introduction: In high-burden settings, low-complexity screening tests for tuberculosis (TB) could expand the reach of community-based case-finding efforts. The potential costs and cost-effectiveness of approaches incorporating these tests are poorly...
4.
Smith J, Cohen T, Dowdy D, Shrestha S, Gandhi N, Hill A
Am J Epidemiol
. 2022 Oct;
192(1):133-145.
PMID: 36227246
The degree to which individual heterogeneity in the production of secondary cases ("superspreading") affects tuberculosis (TB) transmission has not been systematically studied. We searched for population-based or surveillance studies in...
5.
Ryckman T, Robsky K, Cilloni L, Zawedde-Muyanja S, Ananthakrishnan R, Kendall E, et al.
Lancet Infect Dis
. 2022 Aug;
23(2):e59-e66.
PMID: 35963272
The COVID-19 pandemic has disrupted systems of care for infectious diseases-including tuberculosis-and has exposed pervasive inequities that have long marred efforts to combat these diseases. The resulting health disparities often...
6.
Jo Y, Shrestha S, Radnaabaatar M, Park H, Jung J
J Korean Med Sci
. 2022 Jun;
37(23):e189.
PMID: 35698839
Background: Since March 2020, when coronavirus disease 2019 (COVID-19) was declared a pandemic, many countries have applied unprecedented restrictive measures to contain the spread of the virus. This study aimed...
7.
Jo Y, Baik Y, Shrestha S, Pennington J, Gomes I, Reja M, et al.
Epidemiol Infect
. 2022 May;
149:e209.
PMID: 35506926
We developed a novel method to align two data sources (TB notifications and the Demographic Health Survey, DHS) captured at different geographic scales. We used this method to identify sociodemographic...
8.
Lin Q, Shrestha S, Zhao S, Chiu A, Liu Y, Yu C, et al.
Front Med (Lausanne)
. 2022 Mar;
9:810382.
PMID: 35355613
Tuberculosis (TB) incidence has been in steady decline in China over the last few decades. However, ongoing demographic transition, fueled by aging, and massive internal migration could have important implications...
9.
Zafar Ullah A, Shrestha S, Malik A, Roy T
Trop Med Infect Dis
. 2022 Mar;
7(3).
PMID: 35324583
The global fight against tuberculosis (TB) has gained momentum since the adoption of the 'End TB Strategy' in 2014 [...].
10.
Shrestha S, Winglee K, Hill A, Shaw T, Smith J, Kammerer J, et al.
Clin Infect Dis
. 2022 Feb;
75(8):1433-1441.
PMID: 35143641
Background: Reductions in tuberculosis (TB) transmission have been instrumental in lowering TB incidence in the United States. Sustaining and augmenting these reductions are key public health priorities. Methods: We fit...